Experienced clinical scientist passionate about unbiased evidence-based decision-making in drug development. Team player with strong communication, time management, and organizational skills, able to effectively collaborate with a complex set of internal and external stakeholders. Ability to maintain the highest degree of confidentiality, ethical standards, and professionalism.SKILLS AND ACCOMPLISHMENTS* Cross-functional leadership delivering biomarker readouts in clinical drug development to increase Phase 2b success rates.* Provide strategic guidance on the implementation of medical imaging, mobile digital technology, and patient-reported outcomes in clinical trials.* Deliver results through operational excellence by investigator/KOL relationship management, diligent vendor/CRO selection, rigorous clinical data QA and QC, proactive safety monitoring, management of timely study close-out, and internal and external reporting.* Accomplished author of study protocols, clinical development plans/amendments, conference abstracts, and peer-reviewed journal publications.AREAS OF EXPERTISE*Medical imaging (MRI, PET, and other modalities)*Digital wearable technology (activity, sleep, ECG)*Mobile app development*Patient-reported outcomes*Cognition*Quality of life*CSF and serum biomarkers*Alzheimer’s disease*Parkinson’s disease*Lewy body dementia*ALS*FTD*Friedreich ataxia*NAFLD and NASH*Lupus*Ophthalmology*Cardiology*OncologyNONPROFIT COMMITMENTSI serve as Treasurer for the Boston Chapter of the Netherlands-America Foundation, a leading bilateral nonprofit initiating and supporting high-impact exchanges between the Netherlands and the United States, including the NAF-Fulbright fellowships and programs in the arts, history, public policy, and business. I also sit on the Regional Board of my local NEMBA chapter, a nonprofit focused on recreational trail advocacy in New England.